Rapport Therapeutics (RAPP) PT Raised to $53 at BTIG
Tweet Send to a Friend
BTIG analyst Kambiz Yazdi raised the price target on Rapport Therapeutics (NASDAQ: RAPP) to $53.00 (from $47.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
